SalvaRx Group (LSE:SALV)

UK company

Market Info

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info

  • Market Cap£1.650m
  • SymbolLSE:SALV
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINIM00BZ4SS228

Company Profile

SalvaRx Group plc is engaged in drug discovery and development, focused on immune-oncology. SalvaRx invests in novel cancer immuno-therapies and provides its portfolio companies with operational support.